Filing Details

Accession Number:
0001103021-21-000044
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-13 17:36:40
Reporting Period:
2021-05-11
Accepted Time:
2021-05-13 17:36:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301715 A Mark Sirgo C/o Biodelivery Sciences Intl, Inc.,
4131 Parklake Avenue, Suite 225
Raleigh NC 27612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-11 7,500 $3.16 1,098,595 No 4 P Direct
Common Stock Acquisiton 2021-05-12 5,000 $3.24 1,103,595 No 4 P Direct
Common Stock Acquisiton 2021-05-13 3,000 $3.16 1,106,595 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. On May 11, 2021, the Reporting Person purchased an aggregate of 7,500 shares of the Issuer's Common Stock at a weighted average price of $3.16 per share. The highest purchase price for the Common Stock was $3.17 per share and the lowest purchase price was $3.15 per share.
  2. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in these footnotes.
  3. On May 12, 2021, the Reporting Person purchased an aggregate of 5,000 shares of the Issuer's Common Stock at a weighted average price of $3.24 per share. The highest purchase price for the Common Stock was $3.25 per share and the lowest purchase price was $3.22 per share.